{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:12:11Z","timestamp":1774897931658,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":18,"publisher":"Springer US","isbn-type":[{"value":"9781071637852","type":"print"},{"value":"9781071637869","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3786-9_20","type":"book-chapter","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:03:05Z","timestamp":1710950585000},"page":"193-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In Vitro and In Vivo Methods for Analysis of Nanoparticles' Potential to\u00a0Induce Delayed-Type Hypersensitivity Reactions"],"prefix":"10.1007","author":[{"given":"Timothy M.","family":"Potter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry W.","family":"Neun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina A.","family":"Dobrovolskaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"2","key":"20_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jconrel.2013.05.025","volume":"172","author":"MA Dobrovolskaia","year":"2013","unstructured":"Dobrovolskaia MA, McNeil SE (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release 172(2):456\u2013466","journal-title":"J Control Release"},{"issue":"6","key":"20_CR2","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.tiv.2010.05.012","volume":"24","author":"H Sakaguchi","year":"2010","unstructured":"Sakaguchi H, Ryan C, Ovigne JM, Schroeder KR, Ashikaga T (2010) Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials. Toxicol In Vitro 24(6):1810\u20131820","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"20_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/15476910590930100","volume":"2","author":"JL Weaver","year":"2005","unstructured":"Weaver JL, Chapdelaine JM, Descotes J, Germolec D, Holsapple M, House R, Lebrec H, Meade J, Pieters R, Hastings KL, Dean JH (2005) Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions. J Immunotoxicol 2(1):11\u201320","journal-title":"J Immunotoxicol"},{"issue":"6","key":"20_CR4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.tiv.2011.05.030","volume":"25","author":"C Bauch","year":"2011","unstructured":"Bauch C, Kolle SN, Fabian E, Pachel C, Ramirez T, Wiench B, Wruck CJ, van Ravenzwaay B, Landsiedel R (2011) Intralaboratory validation of four in vitro assays for the prediction of the skin sensitizing potential of chemicals. Toxicol In Vitro 25(6):1162\u20131168","journal-title":"Toxicol In Vitro"},{"issue":"7","key":"20_CR5","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.tiv.2012.07.001","volume":"26","author":"Y Nukada","year":"2012","unstructured":"Nukada Y, Ashikaga T, Miyazawa M, Hirota M, Sakaguchi H, Sasa H, Nishiyama N (2012) Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency. Toxicol In Vitro 26(7):1150\u20131160","journal-title":"Toxicol In Vitro"},{"issue":"11","key":"20_CR6","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/jat.2868","volume":"33","author":"A Natsch","year":"2013","unstructured":"Natsch A, Ryan CA, Foertsch L, Emter R, Jaworska J, Gerberick F, Kern P (2013) A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation. J Appl Toxicol 33(11):1337\u20131352","journal-title":"J Appl Toxicol"},{"issue":"5","key":"20_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.tiv.2015.03.009","volume":"29","author":"C Piroird","year":"2015","unstructured":"Piroird C, Ovigne JM, Rousset F, Martinozzi-Teissier S, Gomes C, Cotovio J, Alepee N (2015) The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization. Toxicol In Vitro 29(5):901\u2013916","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"20_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.yrtph.2014.12.008","volume":"71","author":"D Urbisch","year":"2015","unstructured":"Urbisch D, Mehling A, Guth K, Ramirez T, Honarvar N, Kolle S, Landsiedel R, Jaworska J, Kern PS, Gerberick F, Natsch A, Emter R, Ashikaga T, Miyazawa M, Sakaguchi H (2015) Assessing skin sensitization hazard in mice and men using non-animal test methods. Regul Toxicol Pharmacol 71(2):337\u2013351","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"20_CR9","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.tiv.2005.10.014","volume":"20","author":"H Sakaguchi","year":"2006","unstructured":"Sakaguchi H, Ashikaga T, Miyazawa M, Yoshida Y, Ito Y, Yoneyama K, Hirota M, Itagaki H, Toyoda H, Suzuki H (2006) Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicol In Vitro 20(5):774\u2013784","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"20_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.tiv.2005.10.012","volume":"20","author":"T Ashikaga","year":"2006","unstructured":"Ashikaga T, Yoshida Y, Hirota M, Yoneyama K, Itagaki H, Sakaguchi H, Miyazawa M, Ito Y, Suzuki H, Toyoda H (2006) Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicol In Vitro 20(5):767\u2013773","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"20_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10565-008-9059-9","volume":"25","author":"H Sakaguchi","year":"2009","unstructured":"Sakaguchi H, Ashikaga T, Miyazawa M, Kosaka N, Ito Y, Yoneyama K, Sono S, Itagaki H, Toyoda H, Suzuki H (2009) The relationship between CD86\/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test--human cell line activation test (h-CLAT). Cell Biol Toxicol 25(2):109\u2013126","journal-title":"Cell Biol Toxicol"},{"issue":"3","key":"20_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.tiv.2006.10.005","volume":"21","author":"M Miyazawa","year":"2007","unstructured":"Miyazawa M, Ito Y, Yoshida Y, Sakaguchi H, Suzuki H (2007) Phenotypic alterations and cytokine production in THP-1 cells in response to allergens. Toxicol In Vitro 21(3):428\u2013437","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"20_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0887-2333(03)00006-7","volume":"17","author":"Y Yoshida","year":"2003","unstructured":"Yoshida Y, Sakaguchi H, Ito Y, Okuda M, Suzuki H (2003) Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicol In Vitro 17(2):221\u2013228","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"20_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11325-010-0381-0","volume":"15","author":"N Ball","year":"2011","unstructured":"Ball N, Gordon N, Casal E, Parish J (2011) Evaluation of auto bi-level algorithm to treat pressure intolerance in obstructive sleep apnea. Sleep Breath 15(3):301\u2013309","journal-title":"Sleep Breath"},{"issue":"6","key":"20_CR15","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.tiv.2010.07.005","volume":"24","author":"P Aeby","year":"2010","unstructured":"Aeby P, Ashikaga T, Bessou-Touya S, Schepky A, Gerberick F, Kern P, Marrec-Fairley M, Maxwell G, Ovigne JM, Sakaguchi H, Reisinger K, Tailhardat M, Martinozzi-Teissier S, Winkler P (2010) Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program. Toxicol In Vitro 24(6):1465\u20131473","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"20_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.14573\/altex.2011.1.050","volume":"28","author":"G Maxwell","year":"2011","unstructured":"Maxwell G, Aeby P, Ashikaga T, Bessou-Touya S, Diembeck W, Gerberick F, Kern P, Marrec-Fairley M, Ovigne JM, Sakaguchi H, Schroeder K, Tailhardat M, Teissier S, Winkler P (2011) Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment. ALTEX 28(1):50\u201355","journal-title":"ALTEX"},{"issue":"2","key":"20_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/0192623311427572","volume":"40","author":"R Luebke","year":"2012","unstructured":"Luebke R (2012) Immunotoxicant screening and prioritization in the twenty-first century. Toxicol Pathol 40(2):294\u2013299","journal-title":"Toxicol Pathol"},{"key":"20_CR18","unstructured":"Mittar T, Parambar R, McIntyre C (2011) Flow cytometry and high-content imaging to identify markers of monocyte-macrophage differentiation. Application note"}],"container-title":["Methods in Molecular Biology","Characterization of Nanoparticles Intended for Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3786-9_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:04:14Z","timestamp":1710950654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3786-9_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071637852","9781071637869"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3786-9_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"21 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}